CLINICAL_TRIALS
trial_result
· 2022-06-21
Clinical Trial Update: Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy [Phase 3]
Summary
Phase 3 study of edasalonexent in boys with Duchenne Muscular Dystrophy completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Catabasis Pharmaceuticals | Conditions: Muscular Dystrophy, Duchenne | Phase 3 | Status: COMPLETED | Results posted: 2022-06-21